301281 科源制药
已收盘 12-25 15:00:00
资讯
新帖
简况
科源制药控股股东质押534万股股份
新京报网 · 12-24 09:45
科源制药控股股东质押534万股股份
科源制药(301281)股东力诺投资控股集团有限公司质押534万股,占总股本4.93%
证券之星 · 12-23 22:15
科源制药(301281)股东力诺投资控股集团有限公司质押534万股,占总股本4.93%
科源制药收盘下跌5.14%,滚动市盈率67.78倍
金融界 · 12-23 18:29
科源制药收盘下跌5.14%,滚动市盈率67.78倍
科源制药最新公告:拟购买宏济堂99.42%股权
证券之星 · 12-20
科源制药最新公告:拟购买宏济堂99.42%股权
科源制药:拟购买宏济堂99.42%股权
美港电讯 · 12-20
科源制药:拟购买宏济堂99.42%股权
科源制药获得实用新型专利授权:“一种生产沙库巴曲缬沙坦钠的反应釜”
证券之星 · 12-17
科源制药获得实用新型专利授权:“一种生产沙库巴曲缬沙坦钠的反应釜”
科源制药(301281)股东力诺投资控股集团有限公司质押150万股,占总股本1.38%
证券之星 · 11-18
科源制药(301281)股东力诺投资控股集团有限公司质押150万股,占总股本1.38%
科源制药最新公告:全资子公司力诺制药银行账户被冻结
证券之星 · 11-01
科源制药最新公告:全资子公司力诺制药银行账户被冻结
科源制药(301281)10月25日主力资金净卖出8597.16万元
证券之星 · 10-28
科源制药(301281)10月25日主力资金净卖出8597.16万元
科源制药(301281)2024年三季报简析:净利润减40.38%
证券之星 · 10-26
科源制药(301281)2024年三季报简析:净利润减40.38%
异动快报:科源制药(301281)10月25日14点9分触及涨停板
证券之星 · 10-25
异动快报:科源制药(301281)10月25日14点9分触及涨停板
A股并购重组概念股持续走高,上海电气、民德电子、至正股份、大唐电信、电投产融、双成药业、松发股份、华立股份等涨停,科源制药、捷邦科技等涨超10%。
美港电讯 · 10-25
A股并购重组概念股持续走高,上海电气、民德电子、至正股份、大唐电信、电投产融、双成药业、松发股份、华立股份等涨停,科源制药、捷邦科技等涨超10%。
科源制药(301281.SZ)发布前三季度业绩,净利润3968.31万元,同比下降40.38%
智通财经 · 10-24
科源制药(301281.SZ)发布前三季度业绩,净利润3968.31万元,同比下降40.38%
科源制药(301281)9月30日股东户数1.15万户,较上期减少6.2%
证券之星 · 10-24
科源制药(301281)9月30日股东户数1.15万户,较上期减少6.2%
科源制药公布三季报 前三季净利减少40.38%
新浪财经-鹰眼工作室 · 10-24
科源制药公布三季报 前三季净利减少40.38%
科源制药公告,前三季度实现营业收入3.31亿元,同比下降2.88%;归属于上市公司股东的净利润3968.31万元,同比下降40.
美港电讯 · 10-24
科源制药公告,前三季度实现营业收入3.31亿元,同比下降2.88%;归属于上市公司股东的净利润3968.31万元,同比下降40.
10月24日科源制药涨停分析:化学原料药,中药,医药概念热股
证券之星 · 10-24
10月24日科源制药涨停分析:化学原料药,中药,医药概念热股
异动快报:科源制药(301281)10月24日9点45分触及涨停板
证券之星 · 10-24
异动快报:科源制药(301281)10月24日9点45分触及涨停板
A股化学制药板块强势拉升,科源制药20cm涨停,无锡晶海涨超10%,川宁生物、尔康制药、振东制药赛托生物、海辰药业等跟涨。
美港电讯 · 10-24
A股化学制药板块强势拉升,科源制药20cm涨停,无锡晶海涨超10%,川宁生物、尔康制药、振东制药赛托生物、海辰药业等跟涨。
济南前首富高元坤资本版图收缩,宏济堂借道科源制药曲线上市
蓝鲸财经 · 10-23
济南前首富高元坤资本版图收缩,宏济堂借道科源制药曲线上市
公司概况
公司名称:
山东科源制药股份有限公司
所属行业:
医药制造业
上市日期:
2023-04-04
主营业务:
山东科源制药股份有限公司主营业务为化学原料药及其制剂产品的研发、生产和销售。公司主要产品为降糖类、麻醉类、心血管类、化学药品制剂、中间体。公司为高新技术企业,获得山东省认定企业技术中心、山东省技术创新示范企业、省级第一批“现代优势产业集群+人工智能”试点示范企业、省级产业互联网平台示范项目(医药原料药企业智能网络平台)、济南市级博士后创新实践基地、济南市质子泵抑制剂工程研究中心等资质或认可。
发行价格:
44.18
{"stockData":{"symbol":"301281","market":"SZ","secType":"STK","nameCN":"科源制药","latestPrice":30.39,"timestamp":1735110180000,"preClose":31.69,"halted":0,"volume":1636500,"delay":0,"floatShares":68852000,"shares":108000000,"eps":0.4633,"marketStatus":"已收盘","marketStatusCode":5,"change":-1.3,"latestTime":"12-25 15:00:00","open":31.8,"high":31.97,"low":30.28,"amount":50281000,"amplitude":0.0533,"askPrice":30.4,"askSize":72,"bidPrice":30.39,"bidSize":23,"shortable":0,"etf":0,"ttmEps":0.4633,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1735176600000},"adr":0,"adjPreClose":31.69,"symbolType":"stock","openAndCloseTimeList":[[1735090200000,1735097400000],[1735102800000,1735110000000]],"highLimit":34.86,"lowLimit":28.52,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":108290000,"pbRate":2.57,"roa":"--","roe":"2.98%","epsLYR":0.76,"committee":-0.080645,"marketValue":3291000000,"floatMarketCap":2092000000,"peRate":65.594649,"changeRate":-0.041,"turnoverRate":0.0238,"status":1},"requestUrl":"/m/hq/s/301281/wiki","defaultTab":"wiki","newsList":[{"id":"2493741061","title":"科源制药控股股东质押534万股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2493741061","media":"新京报网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493741061?lang=zh_cn&edition=full","pubTime":"2024-12-24 09:45","pubTimestamp":1735004700,"startTime":"0","endTime":"0","summary":"本次质押股份数量为534万股,占其所持股份比例的14.34%,占公司总股本的4.93%。本次股份质押,主要原因系力诺投资为其控股股东力诺集团股份有限公司向齐鲁银行股份有限公司济南泉城支行申请融资提供质押担保。本次质押股份不存在负担重大资产重组等业绩补偿义务。截至目前,力诺投资及其一致行动人持股3724万股,持股比例34.39%,本次质押后,质押股份数量2934万股,占其所持股份的78.79%,占公司总股本的27.09%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122409461695eae75b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122409461695eae75b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","301281","BK0278","601665"],"gpt_icon":0},{"id":"2493630457","title":"科源制药(301281)股东力诺投资控股集团有限公司质押534万股,占总股本4.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493630457","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493630457?lang=zh_cn&edition=full","pubTime":"2024-12-23 22:15","pubTimestamp":1734963315,"startTime":"0","endTime":"0","summary":"证券之星消息,科源制药12月23日公开信息显示,股东力诺投资控股集团有限公司向齐鲁银行股份有限公司济南泉城支行合计质押534.0万股,占总股本4.93%。质押详情见下表:截止本公告日,股东力诺投资控股集团有限公司已累计质押股份2934.0万股,占其持股总数的78.79%,股东济南安富创业投资合伙企业已累计质押股份338.0万股,占其持股总数的53.65%。科源制药主营业务:化学原料药及其制剂产品的研发、生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024122300034662.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301281","BK0239"],"gpt_icon":0},{"id":"2493930737","title":"科源制药收盘下跌5.14%,滚动市盈率67.78倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2493930737","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493930737?lang=zh_cn&edition=full","pubTime":"2024-12-23 18:29","pubTimestamp":1734949773,"startTime":"0","endTime":"0","summary":"12月23日,科源制药今日收盘31.4元,下跌5.14%,滚动市盈率PE达到67.78倍。从行业市盈率排名来看,公司所处的化学制药行业市盈率平均44.38倍,行业中值27.92倍,科源制药排名第110位。股东方面,截至2024年9月30日,科源制药股东户数11520户,较上次减少761户,户均持股市值35.28万元,户均持股数量2.76万股。山东科源制药股份有限公司主营业务为化学原料药及其制剂产品的研发、生产和销售。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2024/12/23182946708638.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","301281"],"gpt_icon":0},{"id":"2492290492","title":"科源制药最新公告:拟购买宏济堂99.42%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2492290492","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492290492?lang=zh_cn&edition=full","pubTime":"2024-12-20 17:30","pubTimestamp":1734687036,"startTime":"0","endTime":"0","summary":"科源制药公告,公司拟向力诺投资控股集团有限公司、力诺集团股份有限公司等39名交易对方发行股份及支付现金购买其持有的山东宏济堂制药集团股份有限公司99.42%股权,并拟向不超过35名符合条件的特定对象发行股份募集配套资金。本次交易构成关联交易,但不构成重组上市。截至公告披露日,本次交易涉及的尽职调查、审计、评估等工作正在进行。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024122000028966.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301281","BK0239"],"gpt_icon":0},{"id":"2492149439","title":"科源制药:拟购买宏济堂99.42%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2492149439","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492149439?lang=zh_cn&edition=full","pubTime":"2024-12-20 17:23","pubTimestamp":1734686633,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0239","BK1574","01477","301281","BK1191"],"gpt_icon":0},{"id":"2492164536","title":"科源制药获得实用新型专利授权:“一种生产沙库巴曲缬沙坦钠的反应釜”","url":"https://stock-news.laohu8.com/highlight/detail?id=2492164536","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492164536?lang=zh_cn&edition=full","pubTime":"2024-12-17 02:27","pubTimestamp":1734373644,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示科源制药新获得一项实用新型专利授权,专利名为“一种生产沙库巴曲缬沙坦钠的反应釜”,专利申请号为CN202420802793.8,授权日为2024年12月17日。今年以来科源制药新获得专利授权9个,较去年同期增加了800%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121700003021.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301281"],"gpt_icon":0},{"id":"2484271886","title":"科源制药(301281)股东力诺投资控股集团有限公司质押150万股,占总股本1.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484271886","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484271886?lang=zh_cn&edition=full","pubTime":"2024-11-18 21:20","pubTimestamp":1731936018,"startTime":"0","endTime":"0","summary":"证券之星消息,科源制药11月18日公开信息显示,股东力诺投资控股集团有限公司向中国邮政储蓄银行股份有限公司济南市分行合计质押150.0万股,占总股本1.38%。质押详情见下表:截止本公告日,股东力诺投资控股集团有限公司已累计质押股份2934.0万股,占其持股总数的78.79%,股东济南安富创业投资合伙企业已累计质押股份338.0万股,占其持股总数的53.65%。科源制药主营业务:化学原料药及其制剂产品的研发、生产和销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111800031374.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301281"],"gpt_icon":0},{"id":"2480008169","title":"科源制药最新公告:全资子公司力诺制药银行账户被冻结","url":"https://stock-news.laohu8.com/highlight/detail?id=2480008169","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480008169?lang=zh_cn&edition=full","pubTime":"2024-11-01 18:20","pubTimestamp":1730456422,"startTime":"0","endTime":"0","summary":"科源制药公告,全资子公司力诺制药银行账户被冻结,截止公告披露日,8个账户合计被冻结资金余额3014.98万元,申请冻结额度为8617.22万元。账户被冻结原因为力诺制药与江苏赛邦药业有限公司发生销售代理合同纠纷,江苏赛邦向法院申请采取保全措施。目前力诺制药尚未收到法院关于本次冻结的正式法律文书或通知。本次银行账户被冻结所涉及诉讼案件尚未开庭审理,对公司本期及期后损益的影响具有不确定性,实际影响以最终诉讼结果为准。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110100037283.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","301281","01477","161121","BK1191","BK0239"],"gpt_icon":0},{"id":"2478711977","title":"科源制药(301281)10月25日主力资金净卖出8597.16万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478711977","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478711977?lang=zh_cn&edition=full","pubTime":"2024-10-28 09:10","pubTimestamp":1730077854,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年10月25日收盘,科源制药报收于50.47元,上涨20.0%,已连续涨停4天,换手率32.13%,成交量22.12万手,成交额10.41亿元。近5日资金流向一览见下表:科源制药融资融券信息显示,融资方面,当日融资买入1.01亿元,融资偿还7037.77万元,融资净买入3054.31万元。科源制药主营业务:化学原料药及其制剂产品的研发、生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102800001853.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301281","BK0239"],"gpt_icon":0},{"id":"2478999878","title":"科源制药(301281)2024年三季报简析:净利润减40.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478999878","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478999878?lang=zh_cn&edition=full","pubTime":"2024-10-26 06:20","pubTimestamp":1729894830,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期科源制药发布2024年三季报。根据财报显示,科源制药净利润减40.38%。截至本报告期末,公司营业总收入3.31亿元,同比下降2.88%,归母净利润3968.31万元,同比下降40.38%。按单季度数据看,第三季度营业总收入9373.71万元,同比下降19.33%,第三季度归母净利润359.2万元,同比下降76.6%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102600005117.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301281"],"gpt_icon":0},{"id":"2478627590","title":"异动快报:科源制药(301281)10月25日14点9分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2478627590","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478627590?lang=zh_cn&edition=full","pubTime":"2024-10-25 14:10","pubTimestamp":1729836632,"startTime":"0","endTime":"0","summary":"证券之星10月25日盘中消息,14点9分科源制药触及涨停板。目前价格50.47,上涨20.0%。其所属行业化学制药目前上涨。该股为化妆品,化学原料药,医药概念热股,当日化妆品概念上涨1.98%,化学原料药概念上涨1.58%,医药概念上涨1.26%。近5日资金流向一览见下表:科源制药主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102500019106.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301281"],"gpt_icon":0},{"id":"2478644987","title":"A股并购重组概念股持续走高,上海电气、民德电子、至正股份、大唐电信、电投产融、双成药业、松发股份、华立股份等涨停,科源制药、捷邦科技等涨超10%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2478644987","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478644987?lang=zh_cn&edition=full","pubTime":"2024-10-25 11:04","pubTimestamp":1729825498,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0010","300656","BK0184","161123","159982","BK0259","BK0272","BK0067","600198","BK0005","BK0124","002693","BK0239","BK0077","BK0188","603268","BK0132","BK0167","BK0136","603991","BK0262","BK0123","BK1546","BK0201","02727","BK0214","BK1205","BK0103","BK0170","603038","BK0125","BK0177","BK0012","301281","BK0196","BK1594","601727","BK0172","BK1522","BK0028","BK0220","BK0148","000958","399300","301326","BK0091","BK0164","BK0035","BK0149"],"gpt_icon":0},{"id":"2477050619","title":"科源制药(301281.SZ)发布前三季度业绩,净利润3968.31万元,同比下降40.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477050619","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477050619?lang=zh_cn&edition=full","pubTime":"2024-10-24 17:23","pubTimestamp":1729761823,"startTime":"0","endTime":"0","summary":"智通财经APP讯,科源制药(301281.SZ)发布2024年第三季度报告,公司前三季度营业收入3.31亿元,同比下降2.88%;归属于上市公司股东的净利润3968.31万元,同比下降40.38%;归属于上市公司股东的扣除非经常性损益的净利润2690.82万元,同比下降54.85%;基本每股收益0.3665元/股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1198879.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301281"],"gpt_icon":0},{"id":"2477934506","title":"科源制药(301281)9月30日股东户数1.15万户,较上期减少6.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477934506","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477934506?lang=zh_cn&edition=full","pubTime":"2024-10-24 17:10","pubTimestamp":1729761043,"startTime":"0","endTime":"0","summary":"证券之星消息,近日科源制药披露,截至2024年9月30日公司股东户数为1.15万户,较6月30日减少761.0户,减幅为6.2%。在化学制药行业个股中,科源制药股东户数低于行业平均水平,截至9月30日,化学制药行业平均股东户数为3.16万户。从股价来看,2024年6月30日至2024年9月30日,科源制药区间涨幅为8.42%,在此期间股东户数减少761.0户,减幅为6.2%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102400028653.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301281"],"gpt_icon":0},{"id":"2477850819","title":"科源制药公布三季报 前三季净利减少40.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477850819","media":"新浪财经-鹰眼工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477850819?lang=zh_cn&edition=full","pubTime":"2024-10-24 16:40","pubTimestamp":1729759200,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 10月24日消息,科源制药发布三季度报告。 公告显示,公司前三季度营业收入330,879,995.68元,同比减少2.88%,归属上市公司股东的净利润39,683,076.25元,同比减少40.38%。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:小浪快报","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2024-10-24/doc-inctryqv6501586.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["301281","BK0239"],"gpt_icon":0},{"id":"2477570508","title":"科源制药公告,前三季度实现营业收入3.31亿元,同比下降2.88%;归属于上市公司股东的净利润3968.31万元,同比下降40.","url":"https://stock-news.laohu8.com/highlight/detail?id=2477570508","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477570508?lang=zh_cn&edition=full","pubTime":"2024-10-24 16:30","pubTimestamp":1729758653,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["301281","BK0239"],"gpt_icon":0},{"id":"2477743135","title":"10月24日科源制药涨停分析:化学原料药,中药,医药概念热股","url":"https://stock-news.laohu8.com/highlight/detail?id=2477743135","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477743135?lang=zh_cn&edition=full","pubTime":"2024-10-24 15:38","pubTimestamp":1729755490,"startTime":"0","endTime":"0","summary":"证券之星消息,科源制药10月24日涨停收盘,收盘价42.06元。该股于9点25分涨停,2次打开涨停,截止收盘封单资金为7615.51万元,占其流通市值2.63%。10月24日的资金流向数据方面,主力资金净流入3614.48万元,占总成交额5.25%,游资资金净流出4416.85万元,占总成交额6.42%,散户资金净流入802.37万元,占总成交额1.17%。近5日资金流向一览见下表:该股为化学原料药,中药,医药概念热股,当日化学原料药概念上涨0.81%,中药概念上涨0.7%,医药概念上涨0.58%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102400020696.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159938","BK0239","09939","301281","BK1161","BK1515","BK1574"],"gpt_icon":0},{"id":"2477551780","title":"异动快报:科源制药(301281)10月24日9点45分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2477551780","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477551780?lang=zh_cn&edition=full","pubTime":"2024-10-24 09:50","pubTimestamp":1729734628,"startTime":"0","endTime":"0","summary":"证券之星10月24日盘中消息,9点45分科源制药触及涨停板。目前价格42.06,上涨20.0%。其所属行业化学制药目前上涨。该股为化学原料药,医药,中药概念热股,当日化学原料药概念上涨1.02%,医药概念上涨0.86%,中药概念上涨0.81%。近5日资金流向一览见下表:科源制药主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102400010065.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301281"],"gpt_icon":0},{"id":"2477651489","title":"A股化学制药板块强势拉升,科源制药20cm涨停,无锡晶海涨超10%,川宁生物、尔康制药、振东制药赛托生物、海辰药业等跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2477651489","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477651489?lang=zh_cn&edition=full","pubTime":"2024-10-24 09:32","pubTimestamp":1729733526,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["399300","300583","01477","300584","BK1191","BK0239","159982","BK0077","BK1574","BK0186","BK0060","BK0028","300267","301281","301301","300158"],"gpt_icon":0},{"id":"2477322885","title":"济南前首富高元坤资本版图收缩,宏济堂借道科源制药曲线上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2477322885","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477322885?lang=zh_cn&edition=full","pubTime":"2024-10-23 22:56","pubTimestamp":1729695360,"startTime":"0","endTime":"0","summary":"此次宏济堂若能借科源制药实现曲线上市,高元坤的资本局也将变阵。目前,力诺投资持有科源制药34.39%股份,并持有宏济堂38.36%的股份。若能成功置入宏济堂资产,科源制药的业绩将得以大幅提升。2019年底,高元坤又筹划将宏济堂和科源制药注入上市公司亚星化学,使旗下资产实现借壳上市。2021年,科源制药递表深交所,并于2023年成功上市。若此次科源制药能够成功收购宏济堂股份,也意味着高元坤规划的资本版图中将少一家上市公司平台。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-10-23/doc-inctqhft6568879.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["301281","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2023-04-04","address":"山东省济南市商河县经济开发区科源街","stockEarnings":[{"period":"1week","weight":-0.033},{"period":"1month","weight":-0.0989},{"period":"3month","weight":0.5766},{"period":"6month","weight":0.4135},{"period":"1year","weight":-0.0223},{"period":"ytd","weight":-0.0582}],"companyName":"山东科源制药股份有限公司","boardCode":"AI0027","perCapita":"5976股","boardName":"医药制造业","registeredCapital":"10829万元","compareEarnings":[{"period":"1week","weight":0.0095},{"period":"1month","weight":0.0387},{"period":"3month","weight":0.1717},{"period":"6month","weight":0.152},{"period":"1year","weight":0.1626},{"period":"ytd","weight":0.1407}],"survey":" 山东科源制药股份有限公司主营业务为化学原料药及其制剂产品的研发、生产和销售。公司主要产品为降糖类、麻醉类、心血管类、化学药品制剂、中间体。公司为高新技术企业,获得山东省认定企业技术中心、山东省技术创新示范企业、省级第一批“现代优势产业集群+人工智能”试点示范企业、省级产业互联网平台示范项目(医药原料药企业智能网络平台)、济南市级博士后创新实践基地、济南市质子泵抑制剂工程研究中心等资质或认可。","serverTime":1735115943685,"listedPrice":44.18,"stockholders":"11520人(较上一季度减少6.20%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"科源制药(301281)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供科源制药(301281)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"科源制药,301281,科源制药股票,科源制药股票老虎,科源制药股票老虎国际,科源制药行情,科源制药股票行情,科源制药股价,科源制药股市,科源制药股票价格,科源制药股票交易,科源制药股票购买,科源制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"科源制药(301281)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供科源制药(301281)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}